TG Therapeutics Inc (NASDAQ:TGTX)

14.55
BATS BZX Real-Time Price
As of 9:50am ET
 +0.30 / +2.11%
Today’s Change
7.25
Today|||52-Week Range
17.35
+77.44%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close14.25
Today’s open14.35
Day’s range14.15 - 14.55
Volume5,906
Average volume (3 months)1,449,976
Market cap$1.2B
Data as of 9:50am ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-19.37%
Earnings growth (this year)+13.82%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,340.12
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.62+2.25%
ADROAduro Biotech Inc+0.20+2.92%
EGRXEagle Pharmaceutical...+0.38+0.69%
ENTAEnanta Pharmaceutica...+3.59+4.09%
Data as of 9:48am ET, 04/26/2018

Financials

Next reporting dateMay 14, 2018
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$152.4K
Annual profit (last year)-$118.5M
Net profit margin-77,749.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
Chief Financial Officer, Secretary &
Treasurer
Sean A. Power
Corporate headquarters
New York, New York

Forecasts